SCHEMBL7619217

SCHEMBL7619217

COCC(COC)Nc1cc(C)nc2c1nnn2-c1c(C)cc(C)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 20/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5600359 0.80 CRHR1 (0.67) CRHR1
SCHEMBL6297543 0.76 CRHR1 (0.56) CRHR1
SCHEMBL6295934 0.74 CRHR1 (0.56) CRHR1
SCHEMBL6093773 0.71 CRHR1 (0.50) CRHR1
SCHEMBL6093661 0.69 CRHR1 (0.45) CRHR1
SCHEMBL5600335 0.69 CRHR1 (0.52) CRHR1
SCHEMBL7624509 0.67 CRHR1 (0.54) CRHR1
SCHEMBL5611393 0.67 CRHR1 (0.52) CRHR1
SCHEMBL6094839 0.67 CRHR1 (0.49) CRHR1
SCHEMBL6093592 0.65 CRHR1 (0.48) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448261-B1 CORTICOTROPIN RELEASING FACTOR ANTAGONISTS; TREATING ANXIETY, DEPRESSION, AND OTHER PSYCHIATRIC AND NEUROLOGICAL DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-09-10 US disclosed
US-6107300-A CORTICOTROPIN RELEASING FACTOR ANTAGONIST; PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS (US) 2000-08-22 US disclosed
EP-0968210-A1 METHOD OF MAKING ARYLAMINO TRIAZOLOPYRIDINES Du Pont Pharmaceuticals Company (US) 2000-01-05 EP disclosed
WO-1998042706-A1 METHOD OF MAKING ARYLAMINO TRIAZOLOPYRIDINES DU PONT PHARMACEUTICALS COMPANY (US) 1998-10-01 WO disclosed